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Abstract.  Soluble fibronectin binds specifically to gly- 
coprotein (GP) IIb-IIIa on thrombin-activated platelets, 
and this binding is not observed with platelets of pa- 
tients with Glanzmann's thrombasthenia (GT) which 
lack GPIIb-IIIa. Here we report that GT platelets re- 
tain the ability to interact with fibronectin-coated sur- 
faces. Adhesion to fibronectin does not require platelet 
activation and is inhibited by soluble fibronectin, anti- 
bodies specific for fibronectin, peptides containing the 
sequence Arg-Gly-Asp and polyclonal antibodies spe- 
cific for band 3 of the chicken embryo fibroblast fibro- 
nectin receptor (anti-band 3).  Using anti-band 3,  we 
have purified a  second fibronectin receptor from hu- 
man platelets, a heterodimer composed of glycopro- 
teins previously designated GPIc and GPIIa. The 
GPIc-IIa complex is found on both GT and normal 
platelets and appears to be identical to the GP138 
kD-GP160 kD complex recently immunopurified by 
Giancotti et al.  (1986. Exp.  Celt Res.  163:47-62)  and 
by Sonnenberg et al.  (1987. J.  Biol.  Chem.  268:10376- 
10383).  In this report, we provide the first evidence 
that GPIc-IIa actually mediates adhesion of platelets to 
fibronectin-coated surfaces. GPIc-IIa thus represents a 
second functional fibronectin receptor,  distinct from 
GPIIb-IIIa, that is largely responsible for the adhesion 
of nonactivated platelets to fibronectin-coated surfaces. 
p 
LATELETS interact in vivo with the subendothelium of 
a damaged blood vessel to form a hemostatic plug. A 
chief component of the subendothelial matrix is the 
adhesive glycoprotein fibronectin (FN).t  In vitro observa- 
tions concerning platelet-FN interactions have shown that 
human platelets will adhere to and spread on surfaces coated 
with FN (8, 13, 19). This process is similar to adhesion medi- 
ated by Arg-Gly-Asp (RGD)-specific cell surface receptors 
of other cells, e.g., fibroblasts or osteosarcoma cells (1, 6, 
9,  I1, 21, 30). It has also been demonstrated that soluble ra- 
dioiodinated FN will specifically bind to the glycoprotein 
(GP) heterodimer GPIIb-IIIa on thrombin-activated platelets 
and that this binding can be inhibited by peptides containing 
the RGD sequence (22, 26). Because of these similarities be- 
tween GPIIb-IIIa and receptors for adhesive glycoproteins, 
GPIro-IIIa has been considered a  likely candidate as the 
mediator of platelet adhesion to solid phase FN. 
Recently, Giancotti et al. (7) demonstrated the presence of 
a glycoprotein complex, distinct from GPIIb-IIIa, which was 
immunopurified using a polyclonal antibody raised against 
the Fn receptor of mouse SR-BALB cells. The isolated com- 
1, Abbreviations used in this paper: FN, fibronectin; GP, glycoprotein; GT, 
Glanzmann's thrombasthenia; LFA,  lymphocyte function-associated anti- 
gen; NR/R, nonreduced/reduced; PG, prostaglandin; VLA, lymphocyte an- 
tigen expressed very late after T-cell  activation. 
ptex  consisted  of two  proteins  with  apparent  molecular 
masses of 160 and 138 kD (nonreduced). Sonnenberg et al. 
(32) have used a rat monoclonal antibody raised against epi- 
thelial cells to immunopurify a similar complex from mice 
and human platelets.  This group identified the complex com- 
ponents as platelet GPIc and GPIIa.  Using a  rabbit poly- 
clonal antibody specific  for band 3 of the chicken embryo 
fibroblast FN receptor (anti-band 3), we have immunopuri- 
fled a complex of two proteins from lysates prepared from 
surface radioiodinated platelets.  These proteins appear to be 
identical to the complex described by Giancotti et al. (7) and 
Sonnenberg, et al. (32).  Analysis by two-dimensional non- 
reduced/reduced (NR/R) SDS-PAGE  reveals  that the puri- 
fied proteins comigrate with platelet membrane glycopro- 
teins Ic and IIa. We present evidence in this report that this 
heterodimer, present on platelets from normal subjects and 
patients with Glanzmanffs thrombasthenia (GT) (24),  repre- 
sents a functional FN receptor mediating the initial adhesion 
of nonactivated platelets to solid-phase FN. 
Materials and Methods 
Platelet Adhesion to FN 
Platelet-rich plasma from normal volunteers or from patients with GT was 
obtained from acid/citrate/dextrose-anticoagulated whole blood by differen- 
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centrifugation at  1,500 g for 20 min at ambient temperature and resuspen- 
sion in Ringer's citrate/dextrose, pH 6.5, containing prostaglandin (PG) E~, 
at 20 ng/ml. 
For radiolabeling, washed platelets (2  ￿  109) were resuspended in 0.4 
ml of normal saline, mixed with 0.4 ml of distilled water and 0.4 ml ("-400 
taCi) of sodium 5~chromate (Amersham Corp., Arlington Heights, IL), and 
incubated at ambient temperature for 30 min. Radiolabeled platetets were 
then washed again three times in Dulbecco's modified Eagle's medium con- 
raining 0.5%  bovine serum albumin (BSA,  Fraction V,  Sigma Chemical 
Co.,  St.  Louis,  MO)  and  20  ng/ml  PGE~ (DME-BSA-PG) and  resus- 
pended in the same buffer at  1  ￿  108/ml. The specific activity of the la- 
beled platelets ranged from 2.6 to 4.2 cpm 5~Cr per  1,000 platelets. 
FN was purified from human plasma as described by Plow and Ginsberg 
(26) and shown to be homogeneous by SDS-PAGE. Coating of plastic mi- 
crotiter trays with FN was carried out at 4~  for 12-18 h, adding 0.1 ml of 
FN  (2  ~tg/ml)  in  It  mM  NaH2PO4,  150 mM NaCI  (PBS) to each well. 
Control wells were coated with BSA at a concentration of 0.5%  (wt/vol). 
Each well was washed twice with 0.5% BSA in PBS, then flooded with 1% 
BSA in PBS,  and incubated for 90 rain at room temperature. 
The adhesion assay  was performed essentially as described by Ill et al. 
(13), except that PGE~ (20 ng/ml) was included in all buffers throughout 
the entire assay and microtiter plates were used instead of 35-ram diam Petri 
dishes.  5~Chromate-labeled  ptatelets  (1  ￿  107) in  DME-BSA-PG  were 
added to the protein-coated wells, and the trays were incubated at 37~  in 
a humidified, CO,, incubator for 30 min. Unbound platelets were removed 
by gentle aspiration, and the wells were rinsed six times with DME-BSA- 
PG. 0.2 ml of 2 % SDS was added to each well to solubilize bound platelets, 
and the entire contents of each well was counted in a gamma counter. The 
number of platelets adhering to each well was calculated from the amount 
of radioactivity present in each well and the specific activity of the labeled 
platelets. 
When testing the ability of IgG antibody to inhibit adhesion, platelets in 
DME-BSA-PG were preincubated for  1 h  at  room temperature with  1.0 
mg/ml rabbit polyclonal IgG or 10 gg/ml murine monoclonal IgG.  In other 
experiments, platelets were preincubated with  1.0  mM  RGDS,  1.0 mM 
GRGDSP  (Peninsula  Laboratories,  Inc.,  Belmont,  CA),  or  1.5  mg/ml 
plasma FN, each presented in the same medium. 
In some experiments, the effect of incubation at 37~  in the presence of 
EDTA was investigated.  Normal platelets were resuspended in DME-BSA- 
PG plus 5  mM  EDTA.  These platelet suspensions were  incubated in  a 
CO2-humidified  incubator  for  15  rain at  37~  then washed, and  resus- 
pended in DME-BSA-PG without EDTA. These EDTA/37~  plate- 
lets were then compared to untreated platelets as described above. 
Immunoblotting 
Normal platelets and platelets from patients with GT were lysed in I% Tri- 
ton X-100 in 50 mM Tris,  pH 6.8, containing l0 mM benzamidine, 0.4 mM 
PMSE  100 gg/ml leupeptin, and 0.04 ~tg/ml pepstatin A. The lysates were 
then centrifuged at 100,000 g for 45 min to pellet insoluble material. Soluble 
proteins in such lysates were prepared for electrophoresis by addition of 2% 
SDS  with or without 5%  l)_,-mercaptoethanol.  Electrophoresis was per- 
formed using a 7% (wt/vol) polyacrylamide gel as described by Laemmli 
(18). The separated proteins were transferred to nitrocellulose membranes, 
and strips encompassing individual lanes were excised. After blocking with 
I% gelatin, the membrane strips were incubated in solutions containing ei- 
ther rabbit anti-GPllb plus GPIlIa or rabbit anti-band 3. The immunoreac- 
tive bands were visualized by incubating the membrane strips in solutions 
containing alkaline phosphatase-conjugated goat, anti-rabbit IgG (Bio-Rad 
Laboratories, Richmond, CA) and then the substrates nitro blue tetrazolium 
and 5-bromo-4-chloro-3-indolyl phosphate (Sigma Chemical Co.). 
Immunopurification and Two-Dimensional NR/R 
SDS-PAGE 
Normal platelets were surface-labeled with  t251 using the lactoperoxidase 
method (23) and solubilized by addition of 1% Triton X-100 in 50 mM Tris 
(pH 7.4),  200 mM NaCI, and  10 mM EDTA.  Included in this tysis buffer 
were  the  proteolytic inhibitors  leupeptin  (100 pg/ml),  benzamidine (10 
raM), pepstatin A (0.02 ~tg/ml), and PMSF (4 mM). The mixtures were cen- 
trifuged at 100,000 g for45 rain at 4~  and the supernatant containing solu- 
ble protein was aspirated and precleared by adsorption with nonimmune 
rabbit IgG coupled to Sepharose CL-4B (Pharmacia Fine Chemicals, Pis- 
cataway, N J). Precleared soluble protein was then mixed with anti-band 3 
conjugated to Sepharose CL-4B, All antibody-coupled Sepharose was pre- 
pared following the manufacturer's instructions. Generally, 200 ~tl of packed 
beads was added to tubes containing 1.0 ml of labeled platelet protein (12.0 
mg). The slurry was incubated overnight at 4~  After washing the beads 
six times with 10 mM Tris (pH 8.6),  2 mM EDTA,  1 M NaCI, plus 0.5% 
Triton  (wash buffer),  bound antigen  was  eluted  by addition of 50  mM 
diethylamine (pH 11.2) plus 0.02%  SDS and incubation for 15 min at room 
temperature. The beads were removed by centrifugation, and the pH of the 
eluted material in the supernatant was immediately neutralized by addition 
of 0.5  M Tris, pH 6.8. 
The eluted, tZ~l-labeled antigens were mixed with 100 gg of nonradiola- 
beled total platelet protein, and the mixture was then made to 2% SDS plus 
10 mM N-ethylmaleimide, incubated at 56~  for 1 h and analyzed by two- 
dimensional NR/R SDS-PAGE as described (15). The resultant gels were 
silver-stained, dried, photographed, dried under vacuum, and subjected to 
autoradiography. 
Results 
Adhesion of Nonactivated Platelets to FN 
In our assay, 285,000  ___ 70,000 (mean  +  SD; n  =  11) 5~Cr- 
labeled,  normal platetets adhere to a  FN-coated  microtiter 
well when incubated at 37~  for 30 min (Fig.  1). This value 
represents ,'.,3 % of the platelets added to each well. Increas- 
ing the incubation to 90 min increases the number of platelets 
adhering per well to '~15 %  of the total number of platelets 
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Figure  1.  Adhesion  of normal  platelets  to  FN-coated  microtiter 
wells.  5tChromate-labeled platelets were preincubated  tbr 60 min 
at 22~  with the following: (1) buffer (n  =  11); (2) soluble FN at 
1.5  mg/ml (n  =  6);  (3)  1.0  mM  RGDS  (n  =  2);  or (4)  1.0 mM 
GRGDSP (n  =  2).  The platelet mixtures were then transferred to 
wells, and the number of bound platelets determined after an addi- 
tional  30-min  incubation  at  37~  In  separate  experiments,  the 
effect of antibodies specific for adhesive proteins was tested. In this 
case, the antibody was preincubated in FN-coated wells, the wells 
were washed free of unbound antibody, and the ability of labeled 
platelets to bind was determined. Antibodies tested included:  (5) 
HFN 36.3  murine anti-human FN monoclonal antibody (n  =  3); 
(6) HFN 7.1 murine anti-human FN monoclonal antibody (n =  3); 
(7) a rabbit anti-human fibrinogen polyclonal antibody (n =  3); or 
(8)  AvW1  murine anti-von Willebrand  factor (n  =  3).  Each bar 
represents the average of several (n) experiments with each experi- 
ment performed in triplicate. The upper limit of I SD for each value 
is indicated by a  thin vertical  line. 
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Figure 2.  Adhesion  of normal, GT, and EDTA/37 platelets  to FN- 
coated microtiter wells and the effect of receptor-specific  antibod- 
ies. Normal platelets  (n  =  11) and platelets  obtained  from GT pa- 
tients (n  =  3) were labeled  with 5~chromate and allowed to adhere 
to FN-coated microtiter  wells. A portion of the normal platelets (n 
=  6) were treated  with 5 mM EDTA at 37~  for 15 min prior to 
inclusion  in the binding  assay. (A) Number of adherent  platelets in 
the absence of  antibody. (B) Effect ofpreincubation with the follow- 
ing antibodies:  (1) anti-band 3 (n  =  5, 24, and  3, respectively); 
(2) murine monoclonal AP-2 (n =  7,6,4); (3) anti-band 3 +  AP-2 
(n =  2,1; EDTA/37 not tested);  (4) rabbit polyclonal anti-GPIlb + 
GPIIIa (n  =  2,1); (5) nonimmune rabbit  IgG (n  =  3,2);  and  (6) 
murine monoclonal AP-1 (n =  3,2,2).  In B, the number of platelets 
adhering to FN-coated wells  was determined and  expressed  as a 
percentage  of normal adhesion, i.e, that observed in the absence of 
antibody (from A). 
added. This increased value represents a solid monolayer of 
platelets  covering the  entire  surface  of the  microtiter  well 
when  viewed by phase  microscopy.  Nonadherent platelets, 
when removed from one well after a 30-min incubation and 
placed  into  a  second  FN-coated well,  adhere  in a  similar 
proportion, even when transfer is repeated up to four times. 
These  findings  indicate  that  adhesion  to  fibronectin,  as 
reported in this article, is not the property of a subpopulation 
of platelets.  The  nonspecific  adhesion  to  albumin-coated 
wells was routinely <1% of that obtained with FN (data not 
shown). 
The  total  number  of platelets  adhering  to  FN  was  de- 
creased to "~36 % of control values if FN was included in the 
binding assay at concentrations i>1.5 mg/ml. A similar inhi- 
bition was also noted when either of the peptides  RGDS or 
GRGDSP  (1.0  mM)  was added,  decreasing  the  number of 
platelets  bound  by 40%  and  68%,  respectively.  Adhesion 
could also be inhibited by a monoclonal antibody (HFN 36.3, 
[American  Tissue  Culture  Collection]  (ATCC)  No.  CRL 
1605) specific for the cell-binding domain of FN, but not by 
a  second monoclonal antibody (HFN 7.1,  ATCC No.  CRL 
1606)  specific for a different domain of the FN molecule. A 
polyclonal rabbit antibody directed against fibrinogen (Dako 
Corp.,  Santa Barbara,  CA) and a  murine monoclonal anti- 
body specific for von Willebrand Factor (AvWl, produced at 
The Blood Center of Southeastern  Wisconsin) failed to in- 
hibit adhesion. 
When compared to untreated  normal platelets,  GT plate- 
lets or normal platelets treated with EDTA at 37~  (EDTA/37) 
exhibit enhanced binding to FN (Fig. 2). In each case, adhe- 
sion was inhibited by anti-band 3 (lane 1 ). Adhesion of nor- 
mal platelets,  but not GT or EDTA/37-treated platelets,  was 
inhibited  by the murine  monoclonal AP-2,  specific for the 
GPIIb-IIIa complex (lane  2).  AP-2 plus  anti-band  3  pro- 
duced a  synergistic effect, the combination inhibiting adhe- 
sion to a greater extent than either antibody alone (lane 3). 
Rabbit polyclonal antibody to GPIIb plus GPIIIa (lane 4) had 
no effect upon the binding of nonactivated normal platelets 
to Fn.  Nonimmune rabbit IgG (lane 5) not only did not in- 
hibit  but actually  enhanced  the adhesion  of control  or GT 
platelets to Fn. AP-1, a murine monoclonal antibody specific 
for platelet GPIb, also had no effect upon platelet  adhesion 
to FN (lane  6). 
Identification of  Antigen(s) Recognized by Anti-Band 3 
Proteins  in  lysates  prepared  from  normal  or  GT  platelets 
were separated by one-dimensional SDS-PAGE, transferred 
to  nitrocellulose,  and  incubated  in  buffer containing  anti- 
band 3  or a  rabbit polyclonal antibody specific  for GP IIb 
plus  GPIIIa (Fig.  3).  Protein  bands  that  had  been  bound 
by antibody  were  visualized  with  alkaline  phosphatase- 
conjugated goat anti-rabbit IgG. Anti-band 3 bound to a pro- 
tein in lysates of either normal or GT platelets with an appar- 
ent molecular mass of 125 kD (nonreduced).  The mobility 
of this protein is identical to that of GPIIa. In contrast, anti- 
body specific for GPIIb plus GPIIIa reacted  with different 
protein bands representing  GPIIb and GPIIIa, respectively. 
The  anti-GPIIb  +  GPIIIa antibodies  reacted  only  faintly 
with  a  protein  band  in  the  GT  platelet  lysate  most  likely 
representing an altered form of GPIIIa. GT platelets,  lacking 
GPIIb-IIIa, thus possess  that component of the  activation- 
independent  receptor  recognized  by  anti-band  3,  namely, 
GPIIa. 
Figure 3.  Immunoblot of normal and GT platelets.  Protein  from 
normal platelets  (lanes  1 and 3) and GT platelets  (lanes 2 and 4) 
were separated  under nonreduced conditions,  transferred  to nitro- 
cellulose,  and incubated with either a rabbit polyclonal specific for 
GPIIb plus IIIa (lanes I and 2) or anti-band 3 (lanes 3 and 4). Reac- 
tive bands  were visualized  using alkaline  phosphatase-conjugated 
secondary antibody.  The positions  of protein  band represented  by 
GPIIb, GPIIIa, and GPIIa are indicated.  The mobilities of molecu- 
lar mass standards  (kD)  are indicated  to the left of the figure. 
Piotrowicz et al. Glycoprotein lc-lla Functions  as Fibronectin Receptor  1361 Figure 4. Immunopurification of anti-band  3 antigen(s) and characterization by two-dimensional NR/R SDS-PAGE. ~-~.~l-labeled  platelets 
were solubilized in Triton X-100 and incubated with anti-band  3-conjugated Sepharose CL-4B. The eluted material was mixed with  100 
I-tg of a nonlabeled total platelet protein and subjected to two-dimensional NR/R SDS-PAGE. The autoradiograph derived from the gel 
is shown in A. The positions occupied by GPllba and GPIIla, as determined in the corresponding silver-stained gel (B), are demarcated 
on the autoradiograph in A. Electrophoresis in the first dimension (nonreduced) was from right to left; in the second dimension (reduced), 
from top to bottom. 
Immunoprecipitation and Two-Dimensional SDS-PAGE 
The  immunopurified,  radioiodinated  antigens  isolated  by 
anti-band 3 affinity chromatography from lysates of normal 
platelets were mixed with soluble protein from nonlabeled 
platelets and analyzed by two-dimensional NR/R SDS-PAGE 
(Fig.  4).  The apparent molecular masses of the  radioiodi- 
nated antigens visualized  in autoradiograms (A)  were then 
deduced by direct comparison to the mobilities of known gly- 
coproteins visualized in the same gel by silver stain (B). Ma- 
terial immunopurified by anti-band 3  is composed of three 
radiolabeled proteins. The most prominent has an apparent 
molecular mass (NR/R) of 125 kD/150 kD. This radioactive 
protein comigrates with GPIIa on the silver-stained gel. The 
second and third components are subunits of a protein that 
has  an  apparent  molecular  mass  nonreduced  of  155  kD. 
Upon reduction, this protein is dissociated into two subunits, 
the larger with an apparent molecular mass of 130 kD, the 
smaller with an apparent molecular mass of 25  kD.  These 
two  subunits  comigrate  with  platelet  GPIca  and  GPIc[~, 
respectively. Since anti-band 3 binds solely to GPIIa in an 
immunoblot assay (Fig. 3), it is thus reasonable to conclude 
that  the  immunopurified  material  is  a  noncovalently  as- 
sociated complex composed of GPIc and GPIIa. 
Discussion 
The  results  of binding  assays  summarized  in  this  report 
confirm that adhesion of nonactivated platelets to FN-coated 
surfaces is a specific interaction, mediated by the cell recog- 
nition sequence of the FN molecule (RGD) (13). The adher- 
ent ptatelets do not appear to represent a platelet subpopula- 
tion  as  evidenced  by  the  repeated  ability  of nonadherent 
platelets,  gently  removed from assay  microtiter wells and 
added to another set of FN-coated microtiter wells, to adhere 
again  at  a  level  identical  to  that  of the  initially  adherent 
platelets, 
The conditions used  in the assay maintain platelets  in a 
quiescent  state.  Ill et al.  (13) have demonstrated,  in assays 
similar to those presented  here,  that  platelets  loaded  with 
[t4C]serotonin do not secrete the label upon adhesion to Fn. 
By enzyme-linked immunoassays using the monoclonal anti- 
body S12 (5), we have determined that platelets adhering to 
FN  also  do  not  exhibit  any  increase  in  expression  of 
GMPI40, an alpha granule membrane glycoprotein (GMP) 
whose  surface  expression can  be  shown  to  increase  upon 
platelet activation (data not shown),  Furthermore,  the  fact 
that nonadherent  platelets,  when repeatedly removed from 
assay wells and added to fresh FN-coated wells, continue to 
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adherent platelets do not represent a subpopulation of plate- 
lets  which  were  activated  in  the  wash  procedure.  These 
results confirm that platelets adhering to FN in our assay are 
not  activated,  at  least  as  monitored by  assessing  platelet 
secretion and  expression of alpha  granule membrane an- 
tigens. 
The adhesion of nonactivated platelets to FN-coated sur- 
faces cannot be explained solely by the interaction of GPIIb- 
IIIa with FN.  First,  GPIIb-IIIa is an activation-dependent 
receptor, and platelet stimulation by, e.g., thrombin is re- 
quired in  order that soluble,  radioiodinated FN  is  bound 
(26).  Secondly,  platelets  from patients  with  GT,  lacking 
GPIIb-IIIa, still adhere to FN as welt as or better than normal 
platelets.  This result can be mimicked by treating normal 
platelets with EDTA at 37~  for 15 min, a treatment previ- 
ously shown,  by crossed  immunoelectrophoresis, to  irre- 
versibly alter the GPIIb-IIIa complex and to destroy its abil- 
ity to bind fibrinogen (17). 
If GPIIb-IIIa is not required for the adhesion of nonacti- 
vated platelets to FN, then additional receptors may be in- 
volved. Giancotti et al. (7) have shown that a complex of two 
platelet membrane proteins cross-reacts with polyclonal an- 
tibodies raised against the FN receptor of mouse SR-BALB 
cells. Sonnenberg et al. (32) have confirmed the existence of 
a platelet glycoprotein heterodimer composed of GPIc and 
GPIIa.  We have immunopurified a  glycoprotein complex 
from human platelets by anti-band 3 affinity chromatogra- 
phy which is apparently identical to that described by Gian- 
cotti et al.  (7) and Sonnenberg et al.  (32). On two-dimen- 
sional NR/R SDS-PAGE gels, the immunopurified complex 
comigrates with platelet membrane glycoproteins designated 
GPIc and GPIIa. Since anti-band 3 binds only to GPIIa in 
an immunoblot assay, it is reasonable to conclude that GPIc 
and GPIIa exist as a noncovalently associated complex. 
Our results confirm and extend the observations of Gian- 
cotti et al. (7) and Sonnenberg et al.  (32). We present evi- 
dence, utilizing in a  functional assay,  that GPIc-IIa is the 
receptor responsible for the adhesion of nonactivated plate- 
lets to FN. 
Platelets  thus  possess  two  distinct  FN  receptors,  one 
activation-dependent  (GPIIb-IIIa)  and  another  activation- 
independent (GPIc-IIa). Although  specific for GPIIb-IIIa, 
AP-2 routinely decreases the extent of platelet binding and 
acts synergistically with anti-band 3, further decreasing the 
number of platelets bound.  AP-2 recognizes an epitope on 
the  GPIIb-IIIa complex that  probably  is  proximal  to the 
ligand binding site, as evidenced by the ability of AP-2 to in- 
hibit platelet aggregation and fibrinogen binding (25). There 
are a  number of explanations why AP-2  might exert this 
effect upon the adhesion of nonactivated, normal platelets to 
FN. First, it is conceivable that AP-2 may cross-react with 
GPIc-IIa. This would seem a likely conclusion since both 
GPIc-IIa and GPIIb-IIIa are RGD-dependent FN receptors 
and  the  epitope recognized by  AP-2  may have been con- 
served through the evolution of these proteins. If this were 
the case, however, AP-2 would have inhibited the adhesion 
of both GT platelets  and  normal  platelets.  It seems more 
likely, therefore, that AP-2 affects adhesion via its binding to 
GPIIb-IIIa. Whether this means that a portion of GPIIb-IIIa 
molecules on nonactivated platelets serve as  receptors for 
solid-phase FN or that the binding of AP-2 to GPIIb-IIIa in 
some manner interferes with the adhesion mediated by GPIc- 
IIa remains to be determined. Thus, although not absolutely 
necessary for the adhesion of nonactivated platelets to FN, 
GPIIb-IIIa must exert an important effect upon this adhesion. 
The adhesion of nonactivated platelets to FN-coated sur- 
faces is a two-step process: platelets first attach and then they 
spread. If platelets were to attach to FN but show a reduced 
capacity to spread,  a  larger area of exposed FN would be 
available  for  the  attachment  of additional  platelets.  This 
would result in a greater number of platelets eventually able 
to cover the FN surface. This might explain why enhanced 
numbers of GT and EDTA/37 platelets adhere to FN.  One 
can hypothesize that GPIIb-IIIa may mediate spreading on 
solid-phase FN. This theory finds support in the recent ob- 
servation of Lawrence and  Gralnick  (20)  that  antibodies 
specific for IIb-IIIa block the spreading of platelets on suben- 
dothelium without inhibiting the initial binding. Along these 
lines,  the  inhibition  of platelet  spreading  by  AP2  might 
decrease the overall attachment of normal platelets to FN- 
coated surfaces. An assessment of the ability of thrombas- 
thenic and EDTA-treated platelets to spread onto FN-coated 
surfaces, and the effects of anti-GPIIb-IIIa and anti-GPIc- 
IIa agents on the attachment and spreading of normal plate- 
lets are the subjects of current studies in our laboratory. 
GPIIb-IIIa is a member of a family of receptors that medi- 
ate adhesion of cells to extracellular matrices. Others include 
integrin,  lymphocyte function-associated antigens  (LFAs) 
and the lymphocyte antigens expressed very late after T-cell 
activation (VLAs) (for a review, see Hynes [12]). It is clear 
that the platelet heterodimer GPIc-IIa must also be included 
in  this  family.  Both  GPIc-IIa  and  GPIIb-IIIa  are  RGD- 
specific  and  composed  of  two  components,  the  elec- 
trophoretic mobilities of which  change in  a  characteristic 
fashion upon reduction. GPIIb-IIIa is fairly unique in that it 
requires cell activation for ligand binding, and it can bind a 
number of different adhesive glycoproteins, including fibrin- 
ogen (2), fibronectin (4, 26, 27), von Willebrand factor (27, 
28, 31), and vitronectin (29). 
The amino acid sequences of LFA-1, the beta chain of the 
chicken  fibronectin  receptor  (integrin),  and  GPIIIa  have 
been published and appear quite homologous (3, 14). Despite 
this homology, it is GPIIa and not GPIIIa that is immunologi- 
cally cross-reactive with antibodies raised against the fibro- 
blast FN receptor used in this study. It is therefore reasonable 
to expect that even greater homology will be found between 
GPIIa and the beta chain of the FN receptor. 
VLA antigens are a series of heterodimer adhesion recep- 
tors composed of an identical beta subunit and one of at least 
five different alpha subunits (10, 33, 34). Antibodies directed 
against the beta subunit block human fibroblast binding to 
both FN and vitronectin and are cross-reactive with chicken 
integrin (33).  Since GPIIa appears to be immunologically 
related to the beta subunit of integrin (band 3), it may repre- 
sent the platelet analogue of the VLA beta chain. Our data 
indicate that platelet GPIc is the alpha subunit of the platelet 
activation-independent FN receptor. GPIc may be homolo- 
gous  to  one of the  VLA  alpha  subunits  since  antibodies 
specific for the VLA-3 alpha subunit crossreact with an alpha 
chain of chicken integrin (33).  Furthermore, VLA-3 alpha 
has an apparent molecular mass (nonreduced/reduced) very 
similar to that of platelet GPIc. 
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